Misleading Marketing Costs Scios, of J&J, $85 Million
Scios, a Johnson & Johnson subsidiary, pled guilty on Thursday for falsely marketing Natrecor, a heart failure drug, according to recent news sources. Scios was charged with a misdemeanor violation of the Food, Drug and Cosmetic Act. The U.S. has also sued Scios in a related case under the False Claims Act in California. Scios… read more